Aurobindo Pharma rises on expectations to get first biosimilar approval in US in 12-18 months — Intraday Equity Tips

Aurobindo Pharma is currently trading at Rs. 813.00, up by 2.70 points or 0.33% from its previous closing of Rs. 810.30 on the BSE..90 and has touched a high and low of Rs. 815.30 and Rs. 802.30 respectively. So far 56559 shares were traded on the counter. The BSE group ‘A’ stock of face value […]

via Aurobindo Pharma rises on expectations to get first biosimilar approval in US in 12-18 months — Intraday Equity Tips

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s